(TRVI) Trevi Therapeutics - Performance 135.8% in 12m
Compare TRVI with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
48.77%
#21 in Group
Rel. Strength
97.33%
#214 in Universe
Total Return 12m
135.84%
#12 in Group
Total Return 5y
175.30%
#12 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -7.97%
7th Percentile in Group
12m Total Return: TRVI (135.8%) vs XLV (1.7%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
| LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
| NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
| SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
| NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
| SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
| SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: TRVI vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TRVI
| Total Return (including Dividends) | TRVI | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 9.86% | -3.79% | -0.87% |
| 3 Months | 75.38% | -3.99% | -7.58% |
| 12 Months | 135.84% | 1.72% | 11.88% |
| 5 Years | 175.30% | 55.40% | 110.33% |
| Trend Score (consistency of price movement) | TRVI | XLV | S&P 500 |
| 1 Month | 62.4% | -3.2% | 23% |
| 3 Months | 71.9% | -71.4% | -88.5% |
| 12 Months | 84.3% | -17.5% | 55.1% |
| 5 Years | 8.30% | 89.8% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #44 | 14.2% | 10.8% |
| 3 Month | #3 | 82.7% | 89.8% |
| 12 Month | #12 | 132% | 111% |
| 5 Years | #12 | 77.2% | 30.9% |
FAQs
Does TRVI Trevi Therapeutics outperforms the market?
Yes,
over the last 12 months TRVI made 135.84%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months TRVI made 75.38%, while XLV made -3.99%.
Over the last 3 months TRVI made 75.38%, while XLV made -3.99%.
Performance Comparison TRVI vs Indeces and Sectors
TRVI vs. Indices TRVI is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 6.64% | 10.7% | 136% | 124% |
| US NASDAQ 100 | QQQ | 5.61% | 8.46% | 136% | 123% |
| US Dow Jones Industrial 30 | DIA | 7.58% | 13.0% | 137% | 127% |
| German DAX 40 | DAX | 7.87% | 8.54% | 117% | 111% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 10.6% | 12.7% | 139% | 130% |
| Hongkong Hang Seng | HSI | 7.63% | 9.80% | 135% | 122% |
| India NIFTY 50 | INDA | 9.48% | 5.80% | 136% | 133% |
| Brasil Bovespa | EWZ | 7.44% | 5.26% | 133% | 142% |
TRVI vs. Sectors TRVI is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.39% | 10.9% | 130% | 112% |
| Consumer Discretionary | XLY | 6.56% | 9.96% | 134% | 123% |
| Consumer Staples | XLP | 10.1% | 9.66% | 131% | 125% |
| Energy | XLE | 11.1% | 23.7% | 142% | 147% |
| Financial | XLF | 8.03% | 12.0% | 129% | 113% |
| Health Care | XLV | 6.72% | 13.7% | 138% | 134% |
| Industrial | XLI | 6.22% | 9.75% | 136% | 126% |
| Materials | XLB | 7.25% | 12.3% | 144% | 139% |
| Real Estate | XLRE | 8.16% | 11.2% | 137% | 118% |
| Technology | XLK | 4.19% | 8.17% | 140% | 128% |
| Utilities | XLU | 9.48% | 9.80% | 134% | 114% |
| Aerospace & Defense | XAR | 5.69% | 3.47% | 123% | 109% |
| Biotech | XBI | 5.34% | 7.58% | 149% | 138% |
| Homebuilder | XHB | 7.33% | 12.1% | 151% | 143% |
| Retail | XRT | 8.21% | 10.4% | 142% | 139% |